B cells promote granulomatous inflammation during chronic Mycobacterium tuberculosis infection in mice
暂无分享,去创建一个
Jinghang Zhang | A. Steyn | J. Chan | K. Nargan | Yanhua Wang | P. Salgame | P. Maglione | Yong Chen | Tarina Sharma | Jiayong Xu | S. Bharrhan | Sushma Bharrhan | Kievershen Nargan
[1] D. Sherman,et al. Early alveolar macrophage response and IL-1R-dependent T cell priming determine transmissibility of Mycobacterium tuberculosis strains , 2022, Nature Communications.
[2] M. van de Rijn,et al. The immunoregulatory landscape of human tuberculosis granulomas , 2022, Nature Immunology.
[3] S. P. Parihar,et al. IL-4-Responsive B Cells Are Detrimental During Chronic Tuberculosis Infection in Mice , 2021, Frontiers in Immunology.
[4] R. Hunter,et al. µCT Analysis of the Human Tuberculous Lung Reveals Remarkable Heterogeneity in 3D Granuloma Morphology. , 2021, American journal of respiratory and critical care medicine.
[5] W. Bishai,et al. Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis , 2021, Frontiers in Immunology.
[6] W. Bishai,et al. The integrated stress response mediates necrosis in murine Mycobacterium tuberculosis granulomas. , 2020, The Journal of clinical investigation.
[7] D. Alland,et al. Transmission phenotype of Mycobacterium tuberculosis strains is mechanistically linked to induction of distinct pulmonary pathology , 2019, PLoS pathogens.
[8] G. Altan-Bonnet,et al. Cytokine-mediated communication: a quantitative appraisal of immune complexity , 2019, Nature Reviews Immunology.
[9] Chih-Chung Lin,et al. Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection , 2018, The Journal of experimental medicine.
[10] S. Fortune,et al. Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection , 2018, Nature Reviews Immunology.
[11] A. Sher,et al. Type I interferons in tuberculosis: Foe and occasionally friend , 2018, The Journal of experimental medicine.
[12] D. Weissman,et al. Tuberculosis and lung damage: from epidemiology to pathophysiology , 2018, European Respiratory Review.
[13] L. Jouneau,et al. B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis , 2017, American journal of respiratory and critical care medicine.
[14] S. Fortune,et al. Heterogeneity in tuberculosis , 2017, Nature Reviews Immunology.
[15] D. Barber,et al. Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis. , 2017, Cell reports.
[16] W. Jacobs,et al. CD4+ T-cell–independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection , 2016, Proceedings of the National Academy of Sciences.
[17] A. Sharpe,et al. CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease , 2016, PLoS pathogens.
[18] Ping Shen,et al. Antibody-independent functions of B cells: a focus on cytokines , 2015, Nature Reviews Immunology.
[19] P. Roche,et al. Suppression of antigen presentation by IL-10. , 2015, Current opinion in immunology.
[20] P. Fink,et al. ICOS and Bcl6-dependent pathways maintain a CD4 T cell population with memory-like properties during tuberculosis , 2015, The Journal of experimental medicine.
[21] A. Azad,et al. Characterization of Host and Microbial Determinants in Individuals with Latent Tuberculosis Infection Using a Human Granuloma Model , 2015, mBio.
[22] A. Sher,et al. Type I interferons in infectious disease , 2015, Nature Reviews Immunology.
[23] Xuetao Cao,et al. The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review. , 2014, Journal of autoimmunity.
[24] A. Casadevall,et al. The role of B cells and humoral immunity in Mycobacterium tuberculosis infection. , 2014, Seminars in immunology.
[25] Simon A. Jones,et al. Ectopic lymphoid-like structures in infection, cancer and autoimmunity , 2014, Nature Reviews Immunology.
[26] D. Barber,et al. Cutting Edge: Control of Mycobacterium tuberculosis Infection by a Subset of Lung Parenchyma–Homing CD4 T Cells , 2014, The Journal of Immunology.
[27] R. Sobel,et al. MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies , 2013, The Journal of experimental medicine.
[28] B. Bloom,et al. TB or Not TB: That Is No Longer the Question , 2013, Science Translational Medicine.
[29] J. Flynn,et al. B Cells Regulate Neutrophilia during Mycobacterium tuberculosis Infection and BCG Vaccination by Modulating the Interleukin-17 Response , 2013, PLoS pathogens.
[30] L. Ramakrishnan,et al. TNF Dually Mediates Resistance and Susceptibility to Mycobacteria via Mitochondrial Reactive Oxygen Species , 2013, Cell.
[31] F. Lund,et al. IL-17-producing B cells combat parasites , 2013, Nature Immunology.
[32] Robert J Wilkinson,et al. The immune response in tuberculosis. , 2013, Annual review of immunology.
[33] D. Liggitt,et al. Trypanosoma cruzi trans-sialidase initiates an ROR-γt–AHR-independent program leading to IL-17 production by activated B cells , 2013, Nature immunology.
[34] G. Beamer,et al. IL-10 Inhibits Mature Fibrotic Granuloma Formation during Mycobacterium tuberculosis Infection , 2013, The Journal of Immunology.
[35] M. Selman,et al. CXCR5⁺ T helper cells mediate protective immunity against tuberculosis. , 2013, The Journal of clinical investigation.
[36] Ravi S. Misra,et al. Unraveling effector functions of B cells during infection: the hidden world beyond antibody production. , 2012, Infectious disorders drug targets.
[37] John P. Ray,et al. Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections , 2012, Cell.
[38] R. Hunter. Pathology of post primary tuberculosis of the lung: an illustrated critical review. , 2011, Tuberculosis.
[39] A. Azad,et al. Comparative Transcriptional Study of the Putative Mannose Donor Biosynthesis Genes in Virulent Mycobacterium tuberculosis and Attenuated Mycobacterium bovis BCG Strains , 2011, Infection and Immunity.
[40] N. Fujiwara,et al. Human Lung Hydrolases Delineate Mycobacterium tuberculosis–Macrophage Interactions and the Capacity To Control Infection , 2011, The Journal of Immunology.
[41] J. Ernst,et al. Initiation and regulation of T-cell responses in tuberculosis , 2011, Mucosal Immunology.
[42] A. O’Garra,et al. The role of IL-10 in immune regulation during M. tuberculosis infection , 2011, Mucosal Immunology.
[43] S. Rutz,et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. , 2011, Annual review of immunology.
[44] G. Bancroft,et al. Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung , 2010, European journal of immunology.
[45] T. Randall,et al. Effector and regulatory B cells: modulators of CD4+ T cell immunity , 2010, Nature Reviews Immunology.
[46] T. Randall,et al. In a Murine Tuberculosis Model, the Absence of Homeostatic Chemokines Delays Granuloma Formation and Protective Immunity1 , 2009, The Journal of Immunology.
[47] Amit Singh,et al. Mycobacterium tuberculosis WhiB3 Maintains Redox Homeostasis by Regulating Virulence Lipid Anabolism to Modulate Macrophage Response , 2009, PLoS pathogens.
[48] D. Flaherty,et al. Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice1 , 2008, The Journal of Immunology.
[49] C. Hawrylowicz,et al. Strategies for use of IL‐10 or its antagonists in human disease , 2008, Immunological reviews.
[50] F. Lund. Cytokine-producing B lymphocytes-key regulators of immunity. , 2008, Current opinion in immunology.
[51] J. Mainardi,et al. The Peptidoglycan of Stationary-Phase Mycobacterium tuberculosis Predominantly Contains Cross-Links Generated by l,d-Transpeptidation , 2008, Journal of bacteriology.
[52] M. Palmer,et al. Associations between cytokine gene expression and pathology in Mycobacterium bovis infected cattle. , 2007, Veterinary immunology and immunopathology.
[53] T. Laskay,et al. Interferon‐gamma‐dependent mechanisms of mycobacteria‐induced pulmonary immunopathology: the role of angiostasis and CXCR3‐targeted chemokines for granuloma necrosis , 2007, The Journal of pathology.
[54] J. Chan,et al. B Cells Moderate Inflammatory Progression and Enhance Bacterial Containment upon Pulmonary Challenge with Mycobacterium tuberculosis1 , 2007, The Journal of Immunology.
[55] P. Guermonprez,et al. Antigen presentation by B lymphocytes: how receptor signaling directs membrane trafficking. , 2007, Current opinion in immunology.
[56] W. Britton,et al. Life and death in the granuloma: immunopathology of tuberculosis , 2007, Immunology and cell biology.
[57] D. Bruder,et al. Cellular immunity and lung injury in respiratory virus infection. , 2006, Viral immunology.
[58] Smita Y. Patel,et al. Host genetic factors and mycobacterial infections: lessons from single gene disorders affecting innate and adaptive immunity. , 2006, Microbes and infection.
[59] F. Aloisi,et al. Lymphoid neogenesis in chronic inflammatory diseases , 2006, Nature Reviews Immunology.
[60] J. Flynn,et al. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension , 2006, Cellular microbiology.
[61] Daniel Rodríguez‐Pinto. B cells as antigen presenting cells. , 2005, Cellular immunology.
[62] A. Levine,et al. Eradication of Helicobacter pylori and Resolution of Gastritis in the Gastric Mucosa of IL‐10‐Deficient Mice , 2005, Helicobacter.
[63] H. C. van der Heyde,et al. Plasmodium chabaudi adami: use of the B-cell-deficient mouse to define possible mechanisms modulating parasitemia of chronic malaria. , 2005, Experimental parasitology.
[64] Alimuddin Zumla,et al. Lung remodeling in pulmonary tuberculosis. , 2005, The Journal of infectious diseases.
[65] S. Kaveri,et al. Modulation of Dendritic Cell Maturation and Function by B Lymphocytes1 , 2005, The Journal of Immunology.
[66] I. Orme,et al. Interleukin‐10 production by lung macrophages in CBA xid mutant mice infected with Mycobacterium tuberculosis , 2005, Immunology.
[67] T. Randall,et al. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease. , 2005, Current directions in autoimmunity.
[68] S. Kaufmann,et al. Human tuberculous granulomas induce peripheral lymphoid follicle‐like structures to orchestrate local host defence in the lung , 2004, The Journal of pathology.
[69] T. van der Poll,et al. IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection , 2004, The Journal of Immunology.
[70] Rainer Döffinger,et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[71] J. Flynn,et al. Immunology of tuberculosis. , 2003, Annual review of immunology.
[72] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[73] S. Swain,et al. Reciprocal regulation of polarized cytokine production by effector B and T cells , 2000, Nature Immunology.
[74] K. Elkins,et al. Infection of B Cell-Deficient Mice with CDC 1551, a Clinical Isolate of Mycobacterium tuberculosis: Delay in Dissemination and Development of Lung Pathology1 , 2000, The Journal of Immunology.
[75] Ching Li,et al. A Defect in Interleukin-10 Leads to Enhanced Malarial Disease in Plasmodium chabaudi chabaudi Infection in Mice , 1999, Infection and Immunity.
[76] J. Flynn,et al. Reactivation of Latent Tuberculosis: Variations on the Cornell Murine Model , 1999, Infection and Immunity.
[77] P. Haslett,et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. , 1999, Journal of immunology.
[78] S. Dorman,et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection , 1999, Nature Genetics.
[79] J. Casanova,et al. Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. , 1997, The Journal of clinical investigation.
[80] M. Newport,et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. , 1996, The New England journal of medicine.
[81] A. Sher,et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. , 1996, Journal of immunology.
[82] G. Rook,et al. Pathogenesis of Pulmonary Tuberculosis: an Interplay of Tissue-Damaging and Macrophage-Activating Immune Responses—Dual Mechanisms That Control Bacillary Multiplication , 1994 .
[83] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[84] I. Orme,et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.
[85] M. Farrar,et al. The molecular cell biology of interferon-gamma and its receptor. , 1993, Annual review of immunology.
[86] Klaus Rajewsky,et al. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.
[87] HighWire Press. European respiratory review : an official journal of the European Respiratory Society. , 1991 .
[88] A. Lanzavecchia,et al. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. , 1990, Annual review of immunology.